Rob is a partner in our corporate practice and has a particular focus on venture capital work, acting for high growth technology companies and institutional investors on refinancing transactions and company exits. Rob also works with clients in the private equity sector, where he has experience of acting on buyouts, buy-and-build consolidator projects and related exits.

Many of Rob's clients operate in the life sciences and tech, media and communications sectors, where the technology has been developed at some of the world's leading research institutions based in the UK. Rob has worked on the legal drafting committee for the BVCA's early stage model documents.

Rob joined Osborne Clarke in February 2021 and before that, he had been a partner in another top 50 UK law firm for the previous 13 years where he co-led the venture capital team and headed up the technology sector.


Oxular Limited

Advised Oxular Limited on its £27 million fundraise led by Forbion Partners.

Parkwalk, IP Group, Albion & ETF Partners

Advised management and the institutional shareholders (Parkwalk, IP Group, Albion & ETF Partners) on the sale of Perpetuum Limited to Hitachi Rail Limited.